107 related articles for article (PubMed ID: 34320712)
21. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Zhao Y; Zhang T; Zhao Y; Zhou J
Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
23. FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients.
Han Y; Cui J; Lu Y; Sue S; Arpaia E; Mak TW; Minden MD
Leuk Res; 2012 Nov; 36(11):1339-46. PubMed ID: 22902056
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.
Zhai LL; Zhou J; Zhang J; Tang X; Zhou LY; Yin JY; Vanessa MD; Peng W; Lin J; Deng ZQ
Cancer Biomark; 2017; 18(3):305-312. PubMed ID: 28106537
[TBL] [Abstract][Full Text] [Related]
25. [Expression of WT1 Gene in Bone Marrow of Patients with Acute Myeloid Leukemia and Its Influence on Prognosis].
Zheng YT; Li BX; Sun YJ; Yu CL; Sun QY; Qiao JH; Hu KX; Zuo HL; Dong Z; Ai HS; Guo M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):649-54. PubMed ID: 27342485
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8].
Wang JH; Yao B; Guo M; Qiao JH; Sun QY; Hu KX; Li BX; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):655-61. PubMed ID: 27342486
[TBL] [Abstract][Full Text] [Related]
27. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
[TBL] [Abstract][Full Text] [Related]
28. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
Yan Y; Li X; Gao J
J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
Guo Y
Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
[TBL] [Abstract][Full Text] [Related]
31. [Expression of WT1 gene in children with acute myeloid leukemia].
Tang X; Guo X; Yang X; Xiao H; Sun JJ; Yuan LX; Gao J
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1211-1216. PubMed ID: 27974109
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia.
Li J; Sun CK
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3342-3347. PubMed ID: 29917184
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Significance of CD56 Antigen Expression in Patients with
Sun Y; Wan J; Song Q; Luo C; Li X; Luo Y; Huang X; Ding R; Li H; Hou Y; Huang Y; Xie M; Huang Z; Zhang Y; Ma Y; Wu G; Xu S; Chen J
Biomed Res Int; 2021; 2021():1929357. PubMed ID: 33928145
[TBL] [Abstract][Full Text] [Related]
34. [Expression of homeobox gene HOXA9 in childhood acute leukemia, and its clinical significance].
Jia XH; Zhu LP; Li JC; Wang CC
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):268-72. PubMed ID: 23607948
[TBL] [Abstract][Full Text] [Related]
35. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
Jiang Z; Yu Q; Luo X
J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
[TBL] [Abstract][Full Text] [Related]
36. Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia.
Lin LI; Lin DT; Chang CJ; Lee CY; Tang JL; Tien HF
Br J Haematol; 2002 Jun; 117(4):835-41. PubMed ID: 12060118
[TBL] [Abstract][Full Text] [Related]
37. [Expression of HOXB4, PRDM16 and HOXA9 in Patients with Acute Myeloid Leukemia and Its Clinical Significance].
Li L; Zhao CT; Cui BL; Wu SL; Liu XD; Su Z; Yang J; Wang W; Cui ZG; Zhao HG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):326-31. PubMed ID: 27150986
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
Lian XY; Ma JC; Zhou JD; Zhang TJ; Wu DH; Deng ZQ; Zhang ZH; Li XX; He PF; Yan Y; Lin J; Qian J
J Cell Physiol; 2019 Jun; 234(6):9438-9446. PubMed ID: 30317626
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
